You are here

generics

Generic Drug Approvals Hit Another Record High as Competition, Quality Questions Linger

Generic Drug Approvals Hit Another Record High as Competition, Quality Questions Linger

RAPS.org

Flag link:

Sanofi defends top oncology drug with Jevtana patent win

Sanofi defends top oncology drug with Jevtana patent win

Fierce Pharma

Flag link:

3 generic drugmakers accused of 'stonewalling' congressional probe

3 generic drugmakers accused of 'stonewalling' congressional probe

Beckers Hospital Review

Teva Pharmaceutical

Heritage Pharmaceuticals

Flag link:

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA

Fierce Pharma

Teva Pharmaceutical

Flag link:

What Enbrel needs to do after its patent win

What Enbrel needs to do after its patent win

EP Vantage

Flag link:

Enbrel ruling lifts Amgen shares

Enbrel ruling lifts Amgen shares

BioCentury

Flag link:

GAO Pushes FDA to Improve First Cycle Generic Approval Rate

GAO Pushes FDA to Improve First Cycle Generic Approval Rate

RAPS.org

Flag link:

Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff

Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff

Endpoints

Sonorant Therapeutics

Flag link:

Drugmakers master rolling out their own generics to stifle competition

Drugmakers master rolling out their own generics to stifle competition

Fierce Pharma

Hatch Waxman Act

Flag link:

Lyrica Patent Expiration Ushers In 9 Generic Competitors

Lyrica Patent Expiration Ushers In 9 Generic Competitors

Xtalks

Alembic Pharmaceuticals

Alkem Laboratories

MGN Laboratories

Rising Pharmaceuticals

Sciegen Pharmaceuticals

Teva Pharmaceutical

Flag link:

Opioid and price fixing legal liabilities mount for generic companies

Opioid and price fixing legal liabilities mount for generic companies

Biopharma Dive

Teva Pharmaceutical

Flag link:

Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts

Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts

Fierce Pharma

Flag link:

J&J warns generics will bite its pharma unit in the second half

J&J warns generics will bite its pharma unit in the second half

Pharmaforum

Flag link:

Why Isn’t Insulin a Complex Generic? PA Representative Asks FDA

Why Isn’t Insulin a Complex Generic? PA Representative Asks FDA

RAPS.org

Flag link:

Indivior loses appeal to block generic Suboxone opioid treatments

Indivior loses appeal to block generic Suboxone opioid treatments

Reuters

Flag link:

FDA Defends Generic Drug Approvals Despite Dip in June

FDA Defends Generic Drug Approvals Despite Dip in June

RAPS.org

Flag link:

The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls

The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls

Fierce Pharma

drug manufacturing

Flag link:

Supply constraints push EpiPen rival maker Amneal to restructure, shares fall

Supply constraints push EpiPen rival maker Amneal to restructure, shares fall

Endpoints

Flag link:

First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants

First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants

Drug Patent Watch

Flag link:

Sandoz launches oncology generic gefitinib in 13 EU countries

Sandoz launches oncology generic gefitinib in 13 EU countries

Pharmaceutical Business Review

metastatic non-small cell lung cancer

Flag link:

Pages